Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -0.59% and Operating profit at -34.33% over the last 5 years
2
The company has declared Negative results for the last 5 consecutive quarters
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
45.19%
0%
45.19%
6 Months
40.59%
0%
40.59%
1 Year
114.16%
0%
114.16%
2 Years
89.4%
0%
89.4%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shandong Keyuan Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.59%
EBIT Growth (5y)
-34.33%
EBIT to Interest (avg)
50.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.31
Tax Ratio
8.56%
Dividend Payout Ratio
32.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.18%
ROE (avg)
5.63%
Valuation key factors
Factor
Value
P/E Ratio
119
Industry P/E
Price to Book Value
2.11
EV to EBIT
99.15
EV to EBITDA
40.81
EV to Capital Employed
2.29
EV to Sales
6.10
PEG Ratio
NA
Dividend Yield
0.04%
ROCE (Latest)
2.31%
ROE (Latest)
1.78%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
170.20
116.70
45.84%
Operating Profit (PBDIT) excl Other Income
45.50
27.00
68.52%
Interest
0.40
0.00
Exceptional Items
0.20
-0.00
Consolidate Net Profit
33.90
19.60
72.96%
Operating Profit Margin (Excl OI)
188.00%
121.70%
6.63%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 45.84% vs 28.38% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 72.96% vs 35.17% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
396.90
461.90
-14.07%
Operating Profit (PBDIT) excl Other Income
71.90
84.50
-14.91%
Interest
0.10
0.10
Exceptional Items
-16.90
0.70
-2,514.29%
Consolidate Net Profit
16.40
60.30
-72.80%
Operating Profit Margin (Excl OI)
49.50%
80.70%
-3.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -14.07% vs 3.70% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -72.80% vs -21.69% in Dec 2024
About Shandong Keyuan Pharmaceutical Co., Ltd. 
Shandong Keyuan Pharmaceutical Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






